Are there any allergy medications that don't cause panic attacks? This is a genuinely important question for anyone managing both allergies and anxiety. Certain allergy treatments — particularly oral decongestants containing pseudoephedrine or phenylephrine — stimulate the sympathetic nervous system and can trigger palpitations, restlessness, and sensations that mimic or provoke panic attacks. However, several effective alternatives exist that are far less likely to affect the nervous system in this way. Understanding which medications to choose, and which to avoid, can make a significant difference to both your allergy control and your mental wellbeing.

Why Some Allergy Medications May Trigger Anxiety or Panic Attacks

If you have ever felt your heart racing, your chest tightening, or a sudden wave of anxiety after taking allergy medication, you are not alone. Certain allergy treatments can affect the central nervous system in ways that may mimic or worsen anxiety symptoms, and in some individuals this can contribute to feelings that resemble a panic attack.

The most commonly implicated medications are oral decongestants, such as pseudoephedrine and phenylephrine, which are found in many over-the-counter cold and allergy remedies. These work by constricting blood vessels to reduce nasal congestion, but they also stimulate the sympathetic nervous system — the body's 'fight or flight' response. This stimulation can cause:

• Increased heart rate (palpitations)

• Raised blood pressure

• Feelings of restlessness or agitation

• Trembling or sweating

These physical sensations can be distressing in their own right, but for someone already prone to anxiety or panic disorder, they may act as a trigger for a full panic attack.

Important safety information about decongestants: Oral decongestants are contraindicated or should be used with great caution in people with severe or uncontrolled high blood pressure, cardiovascular disease, hyperthyroidism, glaucoma, or an enlarged prostate. They must not be taken alongside monoamine oxidase inhibitors (MAOIs) or within two weeks of stopping them, due to the risk of a dangerous rise in blood pressure. In 2024, the MHRA and EMA issued updated safety advice noting that pseudoephedrine has been rarely associated with serious neurological conditions including posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). If you experience a sudden severe headache, confusion, visual disturbances, or any neurological symptoms while taking a decongestant, stop the medication and seek urgent medical attention.

Decongestant-containing products can be identified by checking the active ingredients list. Look for the words 'pseudoephedrine' or 'phenylephrine' on the label, or for product names that include 'plus', 'D', or 'with decongestant'. Not all products labelled 'non-drowsy' contain a decongestant — many are antihistamine-only formulations.

Not everyone will experience these effects, and individual sensitivity varies considerably. However, if you have a history of anxiety, panic disorder, or a heart condition, it is worth being particularly cautious about medications that contain stimulant decongestants. Always check the patient information leaflet and speak to a pharmacist or GP before starting a new allergy treatment.

If you suspect a medication has caused a side effect, you can report it to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Antihistamines and Their Effects on the Nervous System

Antihistamines are the most widely used class of allergy medication, and they work by blocking histamine H1 receptors to reduce symptoms such as sneezing, itching, and a runny nose. However, not all antihistamines behave in the same way, and their effects on the nervous system differ significantly between generations.

First-generation antihistamines — such as chlorphenamine and promethazine — cross the blood-brain barrier readily. This means they can cause sedation, drowsiness, and in some cases paradoxical excitability, particularly in children and sensitive adults. While sedation is more common than anxiety with these medications, the disruption to normal alertness and cognition can feel unsettling for some people. First-generation antihistamines are generally not recommended for routine use in adults due to their sedating and anticholinergic effects.

Second-generation antihistamines — including cetirizine, loratadine, and fexofenadine — are far less likely to cross the blood-brain barrier and are generally considered to have a more favourable side-effect profile. However, it is important to be aware that central nervous system effects can still occur:

• Cetirizine may cause somnolence and, less commonly, agitation, aggression, insomnia, or mood changes. These psychiatric adverse effects are listed in the UK Summary of Product Characteristics (SmPC), albeit as uncommon or rare.

• Fexofenadine is among the least sedating options available, but insomnia and nervousness are listed as possible adverse effects in its SmPC. Note also that fexofenadine absorption is significantly reduced by fruit juices (including grapefruit, orange, and apple juice); it should be taken with water.

• Loratadine has a low rate of CNS adverse effects, though somnolence is occasionally reported.

Even with second-generation antihistamines, you should avoid driving or operating machinery if you experience drowsiness, as individual responses vary.

For people concerned about anxiety-related side effects, second-generation antihistamines are generally the preferred starting point. That said, if you notice any worsening of anxiety symptoms after starting an antihistamine, discuss this with your GP or pharmacist, who can advise on alternatives. Suspected side effects can be reported via the MHRA Yellow Card Scheme.

Allergy Treatments Less Likely to Cause Anxiety Symptoms

For those who are particularly sensitive to the psychological side effects of allergy medications, several treatment options are considered less likely to provoke anxiety or panic-like symptoms.

Intranasal corticosteroid sprays, such as fluticasone and beclometasone, are recommended by NICE as a first-line treatment for persistent or moderate-to-severe allergic rhinitis, and for cases where nasal symptoms predominate. These sprays work locally within the nasal passages to reduce inflammation and are minimally absorbed into the bloodstream, meaning they have very little systemic effect and are not associated with anxiety or stimulant-type side effects. They are suitable for long-term use in most adults.

To use them effectively and safely:

• Direct the spray away from the nasal septum to reduce the risk of nosebleeds and nasal soreness

• Allow several days of regular use before expecting full benefit

• Be aware that, rarely, systemic effects (such as adrenal suppression) can occur with prolonged high-dose use or when combined with potent CYP3A4 inhibitors (for example, ritonavir or itraconazole); discuss this with your GP or pharmacist if relevant

For mild or intermittent symptoms, an oral antihistamine alone may be sufficient as a first step, in line with NICE CKS guidance.

Sodium cromoglicate (available as eye drops or a nasal spray) works by stabilising mast cells to prevent the release of histamine. It is not a stimulant and has no known association with anxiety symptoms, though it requires regular use (often several times daily) to be effective and is generally considered less effective than intranasal corticosteroids for nasal symptoms.

Allergen immunotherapy (desensitisation) is a longer-term treatment that gradually reduces the immune system's sensitivity to specific allergens. It is available through specialist NHS allergy services and is considered for people with confirmed IgE-mediated allergic disease whose symptoms are not adequately controlled with standard pharmacotherapy. There are two main forms:

• Subcutaneous immunotherapy (SCIT): given as regular injections (typically weekly during build-up, then monthly for maintenance) in a clinical setting with monitoring for anaphylaxis

• Sublingual immunotherapy (SLIT): taken as daily tablets or drops at home, following an initial supervised dose

Both forms require specialist referral and ongoing monitoring. Neither form involves stimulant medications and neither is associated with anxiety-type side effects, though anaphylaxis is a recognised risk with SCIT in particular.

For eye allergy symptoms, antihistamine eye drops such as azelastine or olopatadine act locally and are not significantly absorbed systemically, making them a low-risk option.

In summary, treatments that act locally rather than systemically are generally the safest choice for those with anxiety concerns. Speak to your GP or pharmacist about which option is most appropriate for your symptom pattern and severity.

Talking to Your GP About Allergy Treatment and Mental Health

If you are managing both allergies and anxiety or panic disorder, it is important to have an open conversation with your GP about both conditions together. Treating them in isolation can sometimes lead to medications that inadvertently worsen one condition while addressing the other.

When you speak to your GP, it can be helpful to:

• Bring a list of all current medications, including over-the-counter remedies, supplements, and herbal products

• Describe your anxiety symptoms clearly, including when they occur and whether they seem linked to taking allergy medication

• Mention any previous reactions to specific allergy treatments

• Ask specifically about decongestant-free options, particularly if you have been using combination cold and allergy products

When might your GP refer you to a specialist? According to NICE CKS and BSACI guidance, referral to an NHS allergy clinic is appropriate if:

• Symptoms remain poorly controlled despite optimal first- and second-line treatment

• There is diagnostic uncertainty about the cause of your symptoms

• Occupational allergy is suspected

• You have significant comorbid asthma or severe conjunctival symptoms

• You have experienced a systemic allergic reaction

• Allergen immunotherapy is being considered

At a specialist allergy clinic, investigations are likely to include skin prick testing and/or serum specific IgE blood tests to identify the allergens responsible for your symptoms. These results help guide targeted treatment.

In some cases, your GP may also refer you to a clinical pharmacist or a specialist in respiratory medicine.

It is also worth noting that poorly controlled allergies can themselves worsen anxiety. Chronic symptoms such as sleep disruption caused by nasal congestion, or the unpredictability of allergic reactions, can contribute to heightened anxiety levels. Effective allergy management is therefore an important part of overall mental wellbeing. Your GP can help you find a treatment plan that addresses both concerns safely and in line with current NICE guidance.

Managing Allergies Safely Alongside an Anxiety Condition

Living with both allergies and an anxiety condition requires a thoughtful, personalised approach to treatment. With the right guidance, it is entirely possible to manage allergy symptoms effectively without significantly worsening anxiety.

Practical steps to manage allergies safely include:

• Avoid decongestants where possible. Products containing pseudoephedrine or phenylephrine can be identified by checking the active ingredients list or looking for the words 'plus', 'D', or 'with decongestant' on the packaging. Products labelled 'non-drowsy' are often antihistamine-only formulations and do not necessarily contain a decongestant — always check the ingredients to be sure.

• Choose second-generation antihistamines. Loratadine and fexofenadine are among the least likely to cause central nervous system effects. Take fexofenadine with water rather than fruit juice, as juice can significantly reduce its absorption.

• Use intranasal corticosteroid sprays as a first-line option for persistent or moderate-to-severe hay fever and perennial allergic rhinitis, as recommended by NICE. Use correct technique (directing the spray away from the septum) to minimise local side effects such as nosebleeds.

• Be aware of key interactions. Decongestants must not be used with MAOIs. If you are taking prescribed medication for anxiety — such as selective serotonin reuptake inhibitors (SSRIs) or beta-blockers — always check with your GP or pharmacist before adding any new allergy treatment, as interactions can occasionally occur. The BNF is a useful reference for interaction checking.

• Keep a symptom diary to track whether anxiety symptoms correlate with allergy medication use, seasonal allergen exposure, or other triggers.

• Reduce allergen exposure where practical — for example, using allergen-proof bedding covers for dust mite allergy, monitoring pollen counts during hay fever season, wearing wrap-around sunglasses outdoors, and washing pollen from hair and skin after being outside. Saline nasal irrigation can also help to clear allergens from the nasal passages.

• Avoid driving or operating machinery if you experience drowsiness from any antihistamine, even a second-generation one.

When to seek urgent help: If you or someone with you develops signs of anaphylaxis — including difficulty breathing, swelling of the throat or tongue, or sudden dizziness or collapse — call 999 immediately. If you experience a sudden severe headache, confusion, visual disturbances, or neurological symptoms while taking a decongestant, stop the medication and seek urgent medical attention.

For non-urgent concerns about your allergy medication and mental health, contact your GP surgery or speak to a community pharmacist, who can offer confidential, evidence-based advice without the need for an appointment.

If you think a medication has caused a side effect, please report it to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Frequently Asked Questions